We propose design rules for building organic molecular
bridges
that enable coherent long-distance triplet-exciton transfer. Using
these rules, we describe example polychromophoric structures with
low inner-sphere exciton reorganization energies, low static and dynamic
disorder, and enhanced π-stacking interactions between nearest-neighbor
chromophores. These features lead to triplet-exciton eigenstates that
are delocalized over several units at room temperature. The use of
such bridges in donor–bridge–acceptor assemblies enables
fast triplet-exciton transport over very long distances that is rate-limited
by the donor–bridge injection and bridge–acceptor trapping
rates.
We explain a recent experimental observation that the time-resolved electron paramagnetic resonance spectra of an organic molecule for optical excitation within a highly absorbing region of the molecule has similar intensities to the spectra for optical excitation in a nonabsorbing region [D. L. Meyer et al., J. Phys. Chem. Lett. 8, 1677 (2017)]. We demonstrate that this phenomenon is due to an initial-state preparation effect of photoexcitation that leads to similar initial populations of triplet states for both optical excitation regions. Due to the low intersystem crossing rates, the initial triplet populations are not perturbed on the time scale of the experiment, so they determine the relative intensities of the paramagnetic resonance spectra. The effect is surprising given the weak spin-orbit interactions of organic molecules. Such initial-state preparation effects are likely to occur in systems where the intersystem crossing time scales are long compared to the time scale of the experiment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.